Economy
Total exports to Mainland China down 27% to $147.3b in Q3
Total exports to Mainland China down 27% to $147.3b in Q3
These exports were also for outward processing in the Mainland.
Economy expected to moderate at 3% in 2018
The slowdown in China’s growth may drag economic expansion.
Imports up 7.9% to $378.7b in October
However, a $44b trade deficit was also recorded this month.
8 in 10 professionals bullish on Hong Kong economic growth
Half believe that growth is buoyed by Mainland China’s economy.
6 in 10 professionals admit Mainland China is Hong Kong's strongest competitor
Singapore previously occupied the spot as chief rival.
Exports up 6.7% to $334.7b in October
The Indian export market registered the largest increase.
Inflation rate hit 1.5% in October
Higher food prices drove the marginal increase.
Malaysia smashes forecasts with 6.2% GDP growth in Q3
The growth was driven by a surge in investment and exports.
Hong Kong beats Singapore in attracting expats
Hong Kong's greatest strength lies in its finance skills.
Unemployment rate largely unchanged at 3% from August to October
The underemployment rate similarly went unchanged at 1.1%.
Hong Kong economy grows 3.6% in Q3
It's the fourth consecutive quarter of above-trend economic expansion.
Hong Kong inks free trade and investment agreements with ASEAN
The pacts will take effect in 2019.
Foreign currency reserves down to US$419.2b in October
Assets slipped slightly from US$419.3b in September.
Hong Kong has one of the world's top 20 investment migration programmes
Hong Kong secured the 19th spot.
Hong Kong's consumer prices up 1.4%
Price hikes were seen in take-out meals, transport, and alcohol.
Hong Kong beats Shanghai as Asia's most expensive city
Residential prices in the city soared to an average of US$51,595 psm.
Hong Kong's goods exports up 5.4%
Volume of goods re-exports edged up 5.6%.
Commentary
Hong Kong hospitality: Momentum and the new lifestyle era
Understanding Hong Kong’s new land premium policy
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings